<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.4" extension="2015-08-01"/>
  <id root="566c422a-d74d-4a44-bf01-cc95310d4e72"/>
  <code code="11488-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Consult note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Infectious Diseases Consultation — Arthur Ashe</title>
  <effectiveTime value="20260209120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="3bea76fb-18d3-4675-9dd6-bb6cc8e2e154"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="8dc2fd6e-6bc6-464a-87be-2a6dc861e628" extension="HR-ML013-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-13-6620"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Arthur</given><family>Ashe</family></name>
        <administrativeGenderCode code="M" codeSystem="2.16.840.1.113883.5.1" displayName="Male"/>
        <birthTime value="19800710"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260209120000-0500"/>
    <assignedAuthor><id root="ba006ed6-fd27-47db-adcf-638d3ea08356"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Priyanka</given><family>Rao</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260209120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="ba006ed6-fd27-47db-adcf-638d3ea08356"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Priyanka</given><family>Rao</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <inFulfillmentOf>
    <order><id root="617a8596-bde7-4cab-915d-6e43925f5931"/></order>
  </inFulfillmentOf>
  <documentationOf>
    <serviceEvent classCode="PCPR"><effectiveTime><low value="20260209"/><high value="20260209"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="ba006ed6-fd27-47db-adcf-638d3ea08356"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Priyanka</given><family>Rao</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="6ef62f1d-06dd-4f78-96ef-b38324c4c9b6"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Four-week check of potassium and creatinine, second hepatitis B vaccine, and infectious diseases consultation</originalText></code>
      <effectiveTime><low value="20260209"/><high value="20260209"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="ba006ed6-fd27-47db-adcf-638d3ea08356"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Priyanka</given><family>Rao</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.1" extension="2014-06-09"/>
    <code code="42349-1" codeSystem="2.16.840.1.113883.6.1" displayName="Reason for referral (narrative)"/>
    <title>Reason for Referral</title>
    <text><paragraph>HIV infection diagnosed four months ago with cerebral toxoplasmosis and a CD4 count of 58, in a 45-year-old man who also has coronary artery disease after two bypass operations. Please review his antiretroviral regimen and its interactions with his cardiac medicines, and advise on opportunistic-infection prophylaxis, the monitoring schedule, and vaccines, so that we can co-manage his care. [S]</paragraph><paragraph>Urgency: Routine, within four weeks, on the same day as his four-week primary care visit. [S]</paragraph><paragraph>Questions for the consultant:</paragraph><list listType="ordered"><item>Is bictegravir, emtricitabine, and tenofovir alafenamide the right long-term regimen for him, given his coronary disease and his cardiac medicines, and which antiretroviral drugs should he avoid?</item><item>How long should trimethoprim-sulfamethoxazole maintenance continue, and does he need any other prophylaxis?</item><item>What monitoring schedule do you advise for viral load, CD4 count, and drug safety, and how should we read the rise in his creatinine?</item><item>Which vaccines does he need now, and which should wait for immune recovery?</item><item>Does his HIV infection change the plan for his coronary risk factors?</item></list></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mr. Ashe, a 45-year-old man, is seen at the request of Dr. Tolliver for co-management of HIV. HIV was diagnosed four months ago when he presented with right-hand weakness from cerebral toxoplasmosis, confirmed by stereotactic biopsy; the CD4 count was 58 and the viral load 186,000 copies/mL. He completed six weeks of pyrimethamine, sulfadiazine, and leucovorin and has taken trimethoprim-sulfamethoxazole double strength twice daily since. He started bictegravir, emtricitabine, and tenofovir alafenamide two weeks into toxoplasmosis treatment and has missed no doses. He has had no headache, seizure, fever, rash, or cough, and his right hand has recovered. He acquired HIV, he understands, from a blood transfusion during his second bypass operation; the hospital reported the suspected transfusion-transmitted infection to the blood supplier at diagnosis. He has coronary artery disease after two bypass operations and has no angina. He is clear that he alone decides who learns of his diagnosis. [S]</paragraph><paragraph>Historical basis. These claims are historical evidence, not findings from a modern examination.</paragraph><list><item>Arthur Robert Ashe Jr. was born in Richmond, Virginia, on July 10, 1943, to Mattie Cunningham Ashe and Arthur Robert Ashe Sr.; his mother died before he was seven. [D]</item><item>On July 31, 1979, while teaching tennis to inner-city youth, Ashe had a heart attack, and he then underwent quadruple coronary artery bypass surgery in 1979. [D]</item><item>When chest pain recurred, Ashe had a second bypass operation, a double bypass, in 1983, during which he received a blood transfusion. [D]</item><item>In 1988 Ashe had difficulty moving his right hand and arm; a scan showed a mass in the left side of his brain, which surgeons removed, and the diagnosis was toxoplasmosis. Testing then showed that he had HIV and AIDS. [D]</item><item>Ashe and his doctors concluded that he had almost certainly acquired HIV from a blood transfusion during his 1983 heart operation, before blood was tested for the virus. [D]</item><item>Both of Ashe&apos;s parents had atherosclerotic heart disease at early ages. His mother died at 27 of complications from surgery, and his father had two heart attacks, at 55 and at 59. [D]</item></list><paragraph>2 later historical claims are omitted because they describe events after the index age. See the teaching note.</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="72090b92-7066-4eb7-ba6d-6603ff61ebb6"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260112"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="1957facc-75bc-4105-8af2-894689dafa6a"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, one tablet by mouth once daily; take two hours before or six hours after antacids, calcium, iron, or magnesium</td><td>One tablet by mouth once daily</td><td>Oral route</td><td>2025-09-25</td><td>active</td><td>S</td></tr><tr ID="medication-2"><td>Pyrimethamine 25 mg oral tablet, 200 mg once, then three tablets (75 mg) by mouth daily for six weeks; course completed before intake</td><td>Three tablets by mouth daily after a 200 mg loading dose</td><td>Oral route</td><td>2025-09-11 to 2025-10-23</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Sulfadiazine 500 mg oral tablet, three tablets (1500 mg) by mouth every 6 hours for six weeks; course completed before intake</td><td>Three tablets by mouth every 6 hours</td><td>Oral route</td><td>2025-09-11 to 2025-10-23</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Leucovorin 10 mg oral tablet, two tablets (20 mg) by mouth daily with pyrimethamine; course completed before intake</td><td>Two tablets by mouth daily</td><td>Oral route</td><td>2025-09-11 to 2025-10-23</td><td>completed</td><td>S</td></tr><tr ID="medication-5"><td>Sulfamethoxazole 800 mg and trimethoprim 160 mg (double strength), one tablet by mouth twice daily</td><td>One tablet by mouth twice daily</td><td>Oral route</td><td>2025-10-23 to 2026-10-19</td><td>completed</td><td>S</td></tr><tr ID="medication-6"><td>Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2016-07-31</td><td>active</td><td>S</td></tr><tr ID="medication-7"><td>Atorvastatin 80 mg oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2016-08-01</td><td>active</td><td>S</td></tr><tr ID="medication-8"><td>Ezetimibe 10 mg oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2026-01-12</td><td>active</td><td>S</td></tr><tr ID="medication-9"><td>Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tablet</td><td>One tablet under the tongue every 5 minutes as needed for chest pain, up to 3 doses</td><td>Sublingual route</td><td>2016-08-01</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="52b7453f-13ea-4a52-9a13-a2dcacac4205"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20250925"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1999667" codeSystem="2.16.840.1.113883.6.88" displayName="bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="258fb326-6936-4a63-a87d-d4d7db2f323e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="B20" codeSystem="2.16.840.1.113883.6.90" displayName="Human immunodeficiency virus [HIV] disease"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="bf6f4846-3c9d-4008-8b45-141c86968510"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20250911"/><high value="20251023"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="3"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198182" codeSystem="2.16.840.1.113883.6.88" displayName="pyrimethamine 25 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="4c8ee79e-cf30-40f3-ac61-ee5761846f81"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="B58.2" codeSystem="2.16.840.1.113883.6.90" displayName="Toxoplasma meningoencephalitis"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="083ddb19-f267-435a-b18d-0158fd4f894b"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20250911"/><high value="20251023"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="6" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="3"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198228" codeSystem="2.16.840.1.113883.6.88" displayName="sulfadiazine 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="8b686346-e95f-4903-8899-ef6587172be4"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="B58.2" codeSystem="2.16.840.1.113883.6.90" displayName="Toxoplasma meningoencephalitis"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="69b37c12-ad98-4bc9-ad34-6aa6623798d5"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20250911"/><high value="20251023"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="2"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197860" codeSystem="2.16.840.1.113883.6.88" displayName="leucovorin 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="32d7eaa6-cd68-4133-aa66-1f971cd02a46"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="B58.2" codeSystem="2.16.840.1.113883.6.90" displayName="Toxoplasma meningoencephalitis"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="7c5bc2b8-36b7-4366-a801-d763cbeea10c"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20251023"/><high value="20261019"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="12" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198335" codeSystem="2.16.840.1.113883.6.88" displayName="sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="0f599fcf-b836-410d-a2d8-bce7e8c82c0c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="B20" codeSystem="2.16.840.1.113883.6.90" displayName="Human immunodeficiency virus [HIV] disease"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="52130d54-38d5-44fe-8a69-8a98021d2d38"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="B58.2" codeSystem="2.16.840.1.113883.6.90" displayName="Toxoplasma meningoencephalitis"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="043fd9d8-849c-43d1-88c7-bdd355cbff06"/>
      <text><reference value="#medication-6"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20160731"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="308416" codeSystem="2.16.840.1.113883.6.88" displayName="aspirin 81 MG Delayed Release Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="e0369982-f2ef-4331-8a2d-dcb960b096f7"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="01e7596b-f6b3-462a-aa0e-9193aec2661d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.2" codeSystem="2.16.840.1.113883.6.90" displayName="Old myocardial infarction"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="34bb6778-19a4-4709-b778-94a344474a54"/>
      <text><reference value="#medication-7"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20160801"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="259255" codeSystem="2.16.840.1.113883.6.88" displayName="atorvastatin 80 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="5cc88c64-4b9c-4ebf-a3e2-82960d09d992"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="5d17ccaa-be69-4907-8ea4-2cff0df77c48"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E78.5" codeSystem="2.16.840.1.113883.6.90" displayName="Hyperlipidemia, unspecified"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="b7ba1790-d60b-4875-977b-e58e1bdf7c52"/>
      <text><reference value="#medication-8"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260112"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="349556" codeSystem="2.16.840.1.113883.6.88" displayName="ezetimibe 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="2f73178b-cea8-4ab4-baa3-fba6cb59587b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="f967691c-29ac-4731-832b-3e463f92d239"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E78.5" codeSystem="2.16.840.1.113883.6.90" displayName="Hyperlipidemia, unspecified"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="a709600c-c1f7-4862-8dab-24c89492313b"/>
      <text><reference value="#medication-9"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20160801"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="5" unit="min"/></effectiveTime>
      <routeCode code="C38300" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Sublingual route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198039" codeSystem="2.16.840.1.113883.6.88" displayName="nitroglycerin 0.4 MG Sublingual Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="c843af3c-a3ff-4daa-aa40-58922ed44adf"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>HIV infection, diagnosed about four months before intake with a CD4 count of 58 cells/uL and cerebral toxoplasmosis (an AIDS-defining illness); on antiretroviral therapy since; synthetic modern episode linked to the documented transfusion-acquired infection</td><td>active</td><td>confirmed</td>
    <td>B20</td><td>S — Synthetic modern coding of the documented HIV infection and AIDS diagnosis; B20 stays the code after an AIDS-defining illness, however well the infection is controlled.</td>
  </tr>
  <tr ID="problem-2">
    <td>Cerebral toxoplasmosis, single left-sided lesion with right-hand weakness, diagnosed by stereotactic biopsy; six weeks of acute treatment completed; weakness recovered; on maintenance therapy</td><td>active</td><td>confirmed</td>
    <td>B58.2</td><td>S — Synthetic modern coding of the documented 1988 toxoplasmosis; the modern diagnosis was by biopsy rather than removal of the mass.</td>
  </tr>
  <tr ID="problem-3">
    <td>Coronary artery disease after two bypass operations (quadruple, then double), no angina; synthetic modern episode linked to the documented 1979 and 1983 operations</td><td>active</td><td>confirmed</td>
    <td>I25.10</td><td>S — Synthetic modern diagnosis; the history remains D.</td>
  </tr>
  <tr ID="problem-4">
    <td>Old myocardial infarction at age 36</td><td>active</td><td>confirmed</td>
    <td>I25.2</td><td>S — Synthetic coded history of the documented 1979 heart attack.</td>
  </tr>
  <tr ID="problem-5">
    <td>Hyperlipidemia, on high-intensity statin</td><td>active</td><td>confirmed</td>
    <td>E78.5</td><td>S — Synthetic diagnosis; no cholesterol value from his lifetime is used.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="a65193b1-7181-4d07-8045-6913a197dc9f"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260112"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c6ff12b3-9a5f-42a2-92e4-9b82c99dd824"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260112"/></effectiveTime>
          <value xsi:type="CD" code="B20" codeSystem="2.16.840.1.113883.6.90" displayName="Human immunodeficiency virus [HIV] disease"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="acfae506-6e78-4bcc-b2d8-5a73c191ab3c"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260112"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="38821532-44ab-41ae-8123-5f04a96dc21f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260112"/></effectiveTime>
          <value xsi:type="CD" code="B58.2" codeSystem="2.16.840.1.113883.6.90" displayName="Toxoplasma meningoencephalitis"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="9cd72e44-a0e8-4874-bafb-e54bc004840e"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260112"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="14ce9e2e-7a56-413c-a9bb-f2e02ade1b60"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260112"/></effectiveTime>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="d3be3d69-c7ce-47d8-ab30-c2279cc4b531"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260112"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="1522ec8c-14d9-48f0-86ce-cd12ed88edb1"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260112"/></effectiveTime>
          <value xsi:type="CD" code="I25.2" codeSystem="2.16.840.1.113883.6.90" displayName="Old myocardial infarction"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="642408e8-007c-4ea4-abfb-38eadbcde2f1"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260112"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="9637cdca-b694-4f2e-9800-631d8ee88d3e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-5"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260112"/></effectiveTime>
          <value xsi:type="CD" code="E78.5" codeSystem="2.16.840.1.113883.6.90" displayName="Hyperlipidemia, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-02-09; see the referring visit&apos;s Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well and composed; weight 72.6 kg; blood pressure 116/72</td></tr><tr><td>Mouth</td><td>No thrush or oral hairy leukoplakia</td></tr><tr><td>Lymph nodes</td><td>No enlarged nodes</td></tr><tr><td>Skin</td><td>No rash</td></tr><tr><td>Neurological</td><td>Grip strength and fine finger movements equal on both sides; no focal deficit</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-19"><td>2026-02-09</td><td>Sodium [Moles/volume] in Serum or Plasma</td><td>140</td><td>mmol/L</td><td>135-145 mmol/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-20"><td>2026-02-09</td><td>Potassium [Moles/volume] in Serum or Plasma</td><td>4.8</td><td>mmol/L</td><td>3.5-5.1 mmol/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-21"><td>2026-02-09</td><td>Creatinine [Mass/volume] in Serum or Plasma</td><td>1.16</td><td>mg/dL</td><td>0.74-1.35 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-22"><td>2026-02-09</td><td>Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M</td><td>79</td><td>mL/min/{1.73_m2}</td><td>&gt;=60 mL/min/1.73 m²</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-23"><td>2026-02-09</td><td>Glucose [Mass/volume] in Serum or Plasma</td><td>90</td><td>mg/dL</td><td>70-99 mg/dL</td><td>Normal</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="036f5f5e-6f9b-43b7-9e84-0fd90cc155f9"/>
      <code code="51990-0" codeSystem="2.16.840.1.113883.6.1" displayName="Basic metabolic panel - Blood"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260209"/><high value="20260209"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="974753a4-92c0-4118-87c3-85333a0576b7"/>
          <code code="2951-2" codeSystem="2.16.840.1.113883.6.1" displayName="Sodium [Moles/volume] in Serum or Plasma"/>
          <text><reference value="#result-19"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260209"/>
          <value xsi:type="PQ" value="140" unit="mmol/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>135-145 mmol/L</text>
              <value xsi:type="IVL_PQ"><low value="135" unit="mmol/L"/><high value="145" unit="mmol/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="166a3d5b-263e-4403-a5a9-74f3a29273f7"/>
          <code code="2823-3" codeSystem="2.16.840.1.113883.6.1" displayName="Potassium [Moles/volume] in Serum or Plasma"/>
          <text><reference value="#result-20"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260209"/>
          <value xsi:type="PQ" value="4.8" unit="mmol/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>3.5-5.1 mmol/L</text>
              <value xsi:type="IVL_PQ"><low value="3.5" unit="mmol/L"/><high value="5.1" unit="mmol/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="b19f6765-31f7-47dd-ba1c-b786e548da31"/>
          <code code="2160-0" codeSystem="2.16.840.1.113883.6.1" displayName="Creatinine [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-21"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260209"/>
          <value xsi:type="PQ" value="1.16" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.74-1.35 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.74" unit="mg/dL"/><high value="1.35" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="dfaf82b4-da58-4d6f-a33c-41539e849b63"/>
          <code code="98979-8" codeSystem="2.16.840.1.113883.6.1" displayName="Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M"/>
          <text><reference value="#result-22"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260209"/>
          <value xsi:type="PQ" value="79" unit="mL/min/{1.73_m2}"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>&gt;=60 mL/min/1.73 m²</text>
              <value xsi:type="IVL_PQ"><low value="60" unit="mL/min/{1.73_m2}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="88deb2dc-a916-4b88-a32f-4d9150afc95a"/>
          <code code="2345-7" codeSystem="2.16.840.1.113883.6.1" displayName="Glucose [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-23"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260209"/>
          <value xsi:type="PQ" value="90" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>70-99 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="70" unit="mg/dL"/><high value="99" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.8"/>
    <code code="51848-0" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation note"/>
    <title>Assessment</title>
    <text><list listType="ordered"><item>HIV infection on antiretroviral therapy (B20). Responding well: the viral load has fallen from 186,000 to 42 copies/mL in about 15 weeks and should become undetectable within the next few months, and the CD4 count has risen from 58 to 156. Bictegravir with emtricitabine and tenofovir alafenamide is a recommended first regimen, has a high barrier to resistance, and has no meaningful interaction with aspirin, atorvastatin, ezetimibe, or nitroglycerin. A regimen boosted with ritonavir or cobicistat would raise atorvastatin levels and limit its dose, efavirenz would lower them, and abacavir has been associated with myocardial infarction and should be avoided in a man with coronary disease. [S]</item><item>Cerebral toxoplasmosis on maintenance therapy (B58.2). Clinically resolved. Trimethoprim-sulfamethoxazole double strength twice daily is an accepted maintenance regimen and also prevents Pneumocystis pneumonia. It can stop once the CD4 count has been above 200 for more than six months on ART with a suppressed viral load, provided he remains free of symptoms. Prophylaxis for Mycobacterium avium complex is not needed, because he started fully active ART promptly. [S]</item><item>Creatinine. The rise from 0.98 to about 1.17 mg/dL is expected and stable. Both bictegravir and trimethoprim block tubular secretion of creatinine without lowering the true filtration rate. Potassium is high-normal on trimethoprim and should be watched. [S]</item><item>Vaccines. Inactivated vaccines can be given at any CD4 count, although responses are better as the count recovers. Live vaccines are contraindicated while the CD4 count is below 200; he is immune to measles, mumps, rubella, and varicella and needs none. [S]</item><item>Coronary artery disease and HIV (I25.10). HIV raises cardiovascular risk independently, which strengthens rather than changes the secondary-prevention plan: high-intensity atorvastatin with ezetimibe to an LDL below 55 mg/dL, aspirin, and blood pressure below 130/80. Integrase inhibitors can cause weight gain, which should be tracked. [S]</item></list><paragraph>Data reviewed: Hospital records, including the MRI, the biopsy report, the baseline genotype, and the hepatitis, tuberculosis, and Toxoplasma serologies. Dr. Tolliver&apos;s intake note four weeks ago, with the viral load (42 copies/mL), CD4 count (156), blood count, metabolic panel, ALT, lipid panel, and ECG. Today&apos;s metabolic panel, below. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.10" extension="2014-06-09"/>
    <code code="18776-5" codeSystem="2.16.840.1.113883.6.1" displayName="Plan of care note"/>
    <title>Plan of Treatment</title>
    <text><list><item>Continue bictegravir, emtricitabine, and tenofovir alafenamide once daily; take it two hours before or six hours after any antacid, calcium, iron, or magnesium. [S]</item><item>Avoid abacavir, ritonavir- or cobicistat-boosted regimens, and efavirenz; check any new medicine for interactions with the HIV regimen and with atorvastatin. [S]</item><item>Continue trimethoprim-sulfamethoxazole double strength twice daily; stop it when the CD4 count has been above 200 for more than six months with an undetectable viral load and no symptoms, and restart it if the count falls below 200. [S]</item><item>No Mycobacterium avium complex prophylaxis. [S]</item><item>Viral load and CD4 count every three months until the CD4 count is stably above 200 and prophylaxis has stopped, then every three to six months. [S]</item><item>Blood count, potassium, and creatinine every three months while on trimethoprim-sulfamethoxazole; ALT every six months; lipids per the coronary plan; urine albumin-to-creatinine ratio with the three-month blood tests and then yearly on tenofovir alafenamide, as it was not done at the start of therapy. [S]</item><item>Second hepatitis B vaccine dose today and a surface antibody check one to two months later; second meningococcal ACWY dose at least eight weeks after the first; recombinant zoster vaccine, two doses; influenza and COVID-19 vaccines each autumn; no live vaccines. [S]</item><item>Keep atorvastatin 80 mg and the ezetimibe added today, with an LDL goal below 55 mg/dL; track weight on the integrase inhibitor. [S]</item><item>Anal cancer screening and colorectal cancer screening from age 45, at his preventive visit. [S]</item><item>Share results with him alone, by secure message, unless he asks otherwise; peer support and counseling are available when he wants them. [S]</item><item>Discussed with Dr. Tolliver, who sees him the same day. The findings and plan were explained to Mr. Ashe, who agreed with them; this report is held in the confidential part of the record, and he received his own copy. [S]</item><item>Follow-up: Infectious diseases review after the six-month results, or sooner if the viral load is detectable on any check; primary care continues the three-monthly monitoring between visits. [S]</item></list></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
